Critical Care pulls in $2.6M for cardiac biomarker assay work; Two elements of urine can help predict prostate cancer;

> Critical Care Diagnostics raised $2.6 million toward further development of its Presage ST2 cardiac biomarker assay, which is designed to help doctors assess heart failure. Story

> Two urine-based genetic biomarkers help predict prostate cancer better than either one does on its own, and more accurately than the typical PSA test, Hologic Gen-Probe says its new research indicates. Story (reg. req.)

> Circulating tumor DNA is both an effective biomarker for metastatic breast cancer and an apparent improvement over other biomarkers previously shown to be a reliable measure. Item

> An international group of researchers are calling for the development of biomarkers that can indicate levels of exposure to pollution and the likelihood of developing respiratory disease. Item

> Researchers at Kobe University in Japan have identified several metabolite biomarkers in the blood that may help detect pancreatic cancer sooner than existing diagnostics allow. Story

> LabCorp ($LH) has signed a biomarker testing and laboratory services deal with Bristol-Myers Squibb ($BMY). Story